Citadel Advisors - SIGILON THERAPEUTICS INC ownership

SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 35 filers reported holding SIGILON THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SIGILON THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$10,324
-51.1%
11,100
-81.6%
0.00%
Q4 2022$21,094
+201.3%
60,269
+330.5%
0.00%
Q3 2022$7,000
-82.1%
14,000
-70.1%
0.00%
Q2 2022$39,000
+30.0%
46,845
+329.9%
0.00%
Q4 2021$30,000
-62.5%
10,896
-22.7%
0.00%
Q3 2021$80,000
-48.4%
14,100
-2.4%
0.00%
Q2 2021$155,000
-24.0%
14,446
+57.9%
0.00%
Q1 2021$204,0009,1470.00%
Other shareholders
SIGILON THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 10,370,369$28,622,0000.44%
HARBOURVEST PARTNERS LLC 740,740$2,044,0000.26%
SOUNDMARK WEALTH MANAGEMENT, LLC 25,555$71,0000.05%
Artal Group S.A. 276,000$762,0000.02%
Choate Investment Advisors 66,666$184,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 200,000$552,0000.01%
CANADA PENSION PLAN INVESTMENT BOARD 1,485,185$4,099,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 142,781$394,0000.00%
STATE OF WISCONSIN INVESTMENT BOARD 509,629$1,407,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 234,153$646,0000.00%
View complete list of SIGILON THERAPEUTICS INC shareholders